BridgeBio's Neil Kumar on drug development
- blonca9
- Apr 28, 2023
- 1 min read
Updated: Jun 16, 2023
BridgeBio's Neil Kumar shares some experiences that may be good learnings for other drug developers and discusses his company's unique business model.
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.